Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Nordic Capital"


3 mentions found


A logo on the headquarters of Hargreaves Lansdown Plc in Bristol, UK, on Thursday, Aug. 8, 2024. LONDON — British investment platform Hargreaves Lansdown said on Friday it had agreed to a takeover offer equivalent to £5.4 billion ($6.9 billion) by a group of investors including CVC Group. Shareholders in Hargreaves Lansdown — the U.K.'s biggest stockbroker — will get 1,110 British pence per share and a dividend of 30 pence per share under the deal, the company said. The news comes after the company in May rejected an offer from the consortium of £4.7 billion, or 985 pence per share. At the time, Hargreaves Lansdown said the bid "substantially" undervalued the company and its prospects.
Persons: Hargreaves Lansdown, Abu, Organizations: LONDON, CVC Group, Nordic Capital Locations: Bristol
LONDON, May 4 (Reuters) - U.S. private equity firm Summit Partners is looking to sell a stake in Swiss wealth manager Cinerius Financial Partners amid increasing consolidation in the sector, two people familiar with the matter told Reuters. Summit intends to bring in another private equity fund to help fund Cinerius' growth, particularly through acquisitions, one of the people said. Asset manager BlackRock Inc (BLK.N) provides debt financing for Cinerius' acquisitions through its private credit arm, the person added. BlackRock, Cinerius and Summit Partners did not respond to requests for comment. Belgian private bank Degroof Petercam is reviewing strategic options after drawing interest from rivals, Reuters reported last Friday.
Oct 31 (Reuters) - Thermo Fisher Scientific Inc (TMO.N) said on Monday it would buy specialty diagnostics firm the Binding Site Group from a group led by European private equity firm Nordic Capital in an all-cash transaction valued at 2.25 billion pounds ($2.6 billion). The Birmingham-based company's test helps detect and monitor multiple myeloma, a cancer in a type of white blood cell, and is on track to deliver more than $220 million of revenue in 2022, Thermo Fisher said. Thermo Fisher, which makes scientific instruments, expects the transaction to be completed in the first half of 2023 and boost adjusted earnings per share by 7 cents on the first full-year of ownership. Reporting by Leroy Leo and Pratik Jain in Bengaluru; Editing by Sriraj KalluvilaOur Standards: The Thomson Reuters Trust Principles.
Total: 3